Latest News
Rossari Biotech Limited
- Rossari Biotech Ltd Estimates – NSE:ROSSARI
- Buy Rossari Biotech; target of Rs 520: ICICI Securities
- Buy Rossari Biotech; target of Rs 520: ICICI Securities
- Rossari Biotech Q2FY27 Results: Revenue up 19% YoY to ₹697.6 crore
- Rossari Biotech Q2FY27 slides: record revenue, export surge amid margin pressure
- Earnings call transcript: Rossari Biotech misses revenue estimate in Q2 2026
- Rossari Biotech targets 10–15% growth in FY27, expects profits to double in four years
- Rossari Biotech Reports Record Quarterly Revenue of ₹697.6 Crore in Q2 FY27
- Rossari Biotech Targets Debt-Free Status In Coming Months
- Rossari Biotech Q2 FY27 net profit hits Rs. 3.89 Cr
- Rossari Biotech Q2 Results FY27: PAT up 5.5%, revenue Rs 697.56 Cr
- Rossari Biotech Q2 FY2026 Earnings: Revenue Climbs 15.37% YoY to ₹2,389.82 Crore; EPS at ₹26.93 - Interim Report
Headlines from the last 30 days, linking to the original publishers. See all market news →